Two Mass. Pharmas See Positive Results, Others See Losses

Several Massachusetts pharmaceutical companies announced first quarter financial results, including increases in revenue from Repligen and Zalicus, and net losses from ArQule and Synta Pharmaceuticals.
Mass High Tech